Connection

David Cole to gp100 Melanoma Antigen

Back to Details
This is a "connection" page, showing publications David Cole has written about gp100 Melanoma Antigen.
David Cole
Connection Strength
0.122
gp100 Melanoma Antigen
  1. Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C). J Immunol. 2009 Feb 15; 182(4):2030-40.
    View in: PubMed
    Score: 0.081
  2. Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours. Cancer Treat Rev. 2019 Jul; 77:35-43.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.